View in EDS HTML Full Text PDF Full Text

Timing of intravenous infliximab administration affects inflammatory bowel disease outcomes.

Saved in:
Bibliographic Details
Title: Timing of intravenous infliximab administration affects inflammatory bowel disease outcomes.
Authors: Post Z; Department of Internal Medicine, Division of Digestive Diseases and Nutrition, Rush University Medical Center, Chicago, Illinois, USA., Maniak A; Department of Internal Medicine, Division of Digestive Diseases and Nutrition, Rush University Medical Center, Chicago, Illinois, USA., DeMeo A; Rush University, Rush Medical College, Chicago, Illinois, USA., Keshavarzian A; Department of Internal Medicine, Division of Digestive Diseases and Nutrition, Rush University Medical Center, Chicago, Illinois, USA.; Rush Center for Integrated Microbiome and Chronobiology Research (CIMCR), Rush University Medical Center, Chicago, Illinois, USA.; Departments of Physiology and Anatomy & Cell Biology, Rush University, Chicago, Illinois, USA.
Source: Chronobiology international [Chronobiol Int] 2026 Mar; Vol. 43 (3), pp. 328-338. Date of Electronic Publication: 2025 Dec 15.
Publication Type: Journal Article
Journal Info: Publisher: Informa Healthcare Country of Publication: England NLM ID: 8501362 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-6073 (Electronic) Linking ISSN: 07420528 NLM ISO Abbreviation: Chronobiol Int Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41395707
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Timing of intravenous infliximab administration affects inflammatory bowel disease outcomes.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Post+Z%22">Post Z</searchLink>; Department of Internal Medicine, Division of Digestive Diseases and Nutrition, Rush University Medical Center, Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Maniak+A%22">Maniak A</searchLink>; Department of Internal Medicine, Division of Digestive Diseases and Nutrition, Rush University Medical Center, Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22DeMeo+A%22">DeMeo A</searchLink>; Rush University, Rush Medical College, Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Keshavarzian+A%22">Keshavarzian A</searchLink>; Department of Internal Medicine, Division of Digestive Diseases and Nutrition, Rush University Medical Center, Chicago, Illinois, USA.; Rush Center for Integrated Microbiome and Chronobiology Research (CIMCR), Rush University Medical Center, Chicago, Illinois, USA.; Departments of Physiology and Anatomy & Cell Biology, Rush University, Chicago, Illinois, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228501362%22">Chronobiology international</searchLink> [Chronobiol Int] 2026 Mar; Vol. 43 (3), pp. 328-338. <i>Date of Electronic Publication: </i>2025 Dec 15.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Informa+Healthcare%22">Informa Healthcare </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8501362 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1525-6073 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2207420528%22">07420528 </searchLink><i>NLM ISO Abbreviation: </i>Chronobiol Int <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41395707
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/07420528.2025.2599354
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 328
    Titles:
      – TitleFull: Timing of intravenous infliximab administration affects inflammatory bowel disease outcomes.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Post Z
      – PersonEntity:
          Name:
            NameFull: Maniak A
      – PersonEntity:
          Name:
            NameFull: DeMeo A
      – PersonEntity:
          Name:
            NameFull: Keshavarzian A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2026 Mar
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1525-6073
          Numbering:
            – Type: volume
              Value: 43
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Chronobiology international
              Type: main
ResultId 1